Valentino A Demayo, NP
Nurse Practitioner · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Valentino A Demayo’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
State licence records
1 licence
- Washington ARNP.AP.60314068-NPAdvanced Registered Nurse Practitioner License · since 2012 · expires 2015-02-14ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$66,133
Medicare paid this office $66,133 for 254 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 32 | $15,560 | None |
| Aspiration and/or injection of fluid from large joint | 69 | $9,929 | $61 |
| Short return visit (20+ min) | 81 | $8,517 | $74 |
| Replacement of thigh bone and hip joint with prosthesis | 28 | $4,757 | $159 |
| Replacement of knee joint, both sides of knee | 28 | $4,748 | $158 |
See all 10 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 32 | $15,560 | None |
| Aspiration and/or injection of fluid from large joint | 69 | $9,929 | $61 |
| Short return visit (20+ min) | 81 | $8,517 | $74 |
| Replacement of thigh bone and hip joint with prosthesis | 28 | $4,757 | $159 |
| Replacement of knee joint, both sides of knee | 28 | $4,748 | $158 |
| Return visit (30+ min) | 37 | $4,180 | $95 |
| New patient visit (45+ min) | 24 | $3,212 | $134 |
| New patient visit (30+ min) | 23 | $2,096 | $91 |
| Long return visit (40+ min) | 14 | $1,466 | $86 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 30 | $101 | None |
Procedures Medicare counted
| Hip replacement | 31 | More than 77% of doctors who do this |
| Knee replacement | 28 | More than 62% of doctors who do this |
| Laminectomy or laminotomy (partial removal of spine bones) | 1-10 | None |
| Spinal fusion | 14 | More than 31% of doctors who do this |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
254 Original Medicare patients in 2024. Average age 77 · Women 68% · Also on Medicaid 8% · Health risk score 1.00. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 73% · Coronary heart disease 21% · Chronic kidney disease 21% · Diabetes 19% · Atrial fibrillation 19% · Depression 17% · Cancer 15% · Heart failure 14% · COPD 8% · Dementia 8%.
The office billed $355,481, Medicare allowed $85,886 and paid $66,133; for 1,368 services of 47 kinds; $19,537 of it was for drugs given in the office and $46,595 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 254 | 1,368 | 77 | 1.00 | $355,481 | $66,133 |
| 2023 | 215 | 776 | 75 | 0.92 | $279,172 | $53,975 |
| 2022 | 234 | 1,672 | 76 | 0.94 | $315,315 | $64,079 |
| 2021 | 197 | 2,190 | 76 | 1.05 | $317,857 | $60,299 |
| 2020 | 165 | 559 | 76 | 1.16 | $263,589 | $48,392 |
| 2019 | 245 | 893 | 76 | 1.13 | $366,103 | $85,571 |
| 2018 | 183 | 425 | 76 | 1.15 | $205,469 | $36,794 |
| 2017 | 131 | 293 | 76 | 0.90 | $148,904 | $25,961 |
| 2016 | 140 | 413 | 76 | 1.16 | $174,180 | $33,574 |
| 2015 | 173 | 626 | 76 | 1.17 | $214,182 | $41,884 |
| 2014 | 171 | 617 | 76 | 0.95 | $192,077 | $37,739 |
| 2013 | 44 | 79 | 76 | 1.79 | $42,423 | $4,930 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Long return visit (40+ min) | 44 | $10,134 | $143 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 21 | $8,770 | None |
| New patient visit (45+ min) | 55 | $7,012 | $127 |
| Replacement of knee joint, both sides of knee | 33 | $5,700 | $163 |
| Aspiration and/or injection of fluid from large joint | 36 | $5,479 | $61 |
| Replacement of thigh bone and hip joint with prosthesis | 26 | $4,564 | $163 |
| Return visit (30+ min) | 30 | $3,512 | $106 |
| Prosthetic repair of shoulder joint, total shoulder | 13 | $2,390 | $184 |
| Removal of extensive shoulder joint tissue using an endoscope | 11 | $298 | $27 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $51 | None |
2022: 10 services
| Return visit (30+ min) | 56 | $8,594 | $104 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 16 | $8,400 | None |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 16 | $7,902 | None |
| New patient visit (45+ min) | 60 | $7,771 | $130 |
| Aspiration and/or injection of fluid from large joint | 56 | $7,488 | $64 |
| Replacement of knee joint, both sides of knee | 38 | $6,164 | $162 |
| Long return visit (40+ min) | 23 | $3,844 | $148 |
| Prosthetic repair of shoulder joint, total shoulder | 19 | $3,467 | $182 |
| Replacement of thigh bone and hip joint with prosthesis | 11 | $1,781 | $162 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $98 | None |
2021: 10 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 24 | $13,277 | None |
| Aspiration and/or injection of fluid from large joint | 66 | $9,069 | $61 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 20 | $8,046 | None |
| Replacement of knee joint, both sides of knee | 35 | $5,938 | $165 |
| Replacement of thigh bone and hip joint with prosthesis | 32 | $5,284 | $165 |
| Return visit (30+ min) | 33 | $4,114 | $93 |
| New patient visit (45+ min) | 14 | $1,766 | $126 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 33 | $858 | $26 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 25 | $301 | $12 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $48 | None |
2020: 7 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 19 | $11,661 | None |
| Aspiration and/or injection of fluid from large joint | 36 | $8,373 | $59 |
| Replacement of knee joint, both sides of knee | 32 | $5,732 | $174 |
| Return visit (30+ min) | 42 | $5,222 | $86 |
| Replacement of thigh bone and hip joint with prosthesis | 23 | $4,164 | $174 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 14 | $3,959 | None |
| New patient visit (45+ min) | 22 | $2,160 | $98 |
2019: 10 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 34 | $30,577 | None |
| Aspiration and/or injection of fluid from large joint | 91 | $13,266 | $54 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 33 | $7,721 | None |
| Replacement of knee joint, both sides of knee | 36 | $6,455 | $170 |
| New patient visit (45+ min) | 44 | $5,758 | $131 |
| Return visit (30+ min) | 50 | $5,433 | $89 |
| Replacement of thigh bone and hip joint with prosthesis | 20 | $3,570 | $170 |
| Short return visit (20+ min) | 25 | $1,686 | $56 |
| Computer-assisted surgery for muscle and bone procedure | 24 | $449 | $18 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 31 | $101 | None |
2018: 7 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 20 | $7,687 | None |
| Aspiration and/or injection of fluid from large joint | 41 | $5,300 | $58 |
| Replacement of thigh bone and hip joint with prosthesis | 30 | $5,181 | $167 |
| Replacement of knee joint, both sides of knee | 23 | $3,840 | $167 |
| Short return visit (20+ min) | 41 | $2,765 | $59 |
| Short return visit | 15 | $725 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $51 | None |
2017: 5 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 13 | $5,788 | None |
| Replacement of knee joint, both sides of knee | 27 | $4,656 | $166 |
| Replacement of thigh bone and hip joint with prosthesis | 21 | $3,497 | $167 |
| Aspiration and/or injection of fluid from large joint | 19 | $2,726 | $57 |
| Short return visit (20+ min) | 23 | $1,823 | $59 |
2016: 6 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 21 | $10,987 | None |
| Aspiration and/or injection of fluid from large joint | 39 | $5,571 | $55 |
| Replacement of knee joint, both sides of knee | 18 | $3,157 | $166 |
| Replacement of thigh bone and hip joint with prosthesis | 17 | $2,992 | $166 |
| Short return visit (20+ min) | 30 | $1,951 | $49 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $73 | None |
2015: 7 services
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 35 | $9,663 | None |
| Aspiration and/or injection of fluid from large joint | 68 | $9,289 | $55 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 17 | $6,902 | None |
| Short return visit (20+ min) | 66 | $5,631 | $56 |
| Replacement of knee joint, both sides of knee | 22 | $3,830 | $167 |
| Replacement of thigh bone and hip joint with prosthesis | 13 | $2,052 | $158 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $129 | None |
2014: 5 services
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 60 | $13,392 | None |
| Aspiration and/or injection of fluid from large joint | 76 | $9,029 | $48 |
| Short return visit (20+ min) | 59 | $4,226 | $57 |
| Replacement of knee joint, both sides of knee | 17 | $2,988 | $166 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $100 | None |
Drugs they prescribed that Part D paid
$4,327
Pharmacies billed $4,327 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 53% of their Part D prescriptions (260 of 491) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%.
490 generic and fewer than 11 brand-name prescriptions · $4,327 in drug cost · 17 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 39 | $1,019 | $24 |
| Oxycodone | 82 | $526 | $5 |
| Diclofenac | 27 | $509 | $18 |
| Tramadol | 88 | $339 | $3 |
| Ibuprofen | 48 | $302 | $5 |
See all 7 drugs
| Celecoxib | 39 | $1,019 | $24 |
| Oxycodone | 82 | $526 | $5 |
| Diclofenac | 27 | $509 | $18 |
| Tramadol | 88 | $339 | $3 |
| Ibuprofen | 48 | $302 | $5 |
| Gabapentin | 51 | $189 | $3 |
| Hydrocodone-Acetaminophen | 18 | $177 | $6 |
Year by year
| 2024 | 491 | 171 | 53% (260) | None | $4,327 |
| 2023 | 444 | 151 | 53% (235) | None | $6,698 |
| 2022 | 503 | 152 | 50% (252) | None | $6,323 |
| 2021 | 223 | 110 | 58% (130) | 9% | $5,370 |
| 2020 | 223 | 115 | 52% (116) | 16% | $8,739 |
| 2019 | 249 | 127 | 53% (133) | 8% | $5,764 |
| 2018 | 223 | 116 | 66% (147) | None | $4,571 |
| 2017 | 188 | 101 | 68% (128) | None | $4,454 |
| 2016 | 174 | 77 | 49% (85) | 10% | $10,087 |
| 2015 | 173 | 75 | 49% (85) | 23% | $9,869 |
| 2014 | 116 | 56 | 47% (54) | 34% | $9,567 |
| 2013 | 12 | None | None | 0% | $452 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Celecoxib | 49 | $1,620 | $33 |
| Oxycodone | 97 | $568 | $6 |
| Tramadol | 126 | $447 | $4 |
| Diclofenac | 18 | $426 | $24 |
| Ibuprofen | 52 | $381 | $7 |
| Gabapentin | 56 | $142 | $3 |
| Ondansetron | 11 | $124 | $11 |
2022: 7 drugs
| Celecoxib | 46 | $2,145 | $47 |
| Naloxone | 11 | $973 | $88 |
| Oxycodone | 105 | $784 | $7 |
| Tramadol | 139 | $457 | $3 |
| Ibuprofen | 64 | $417 | $7 |
| Gabapentin | 82 | $216 | $3 |
| Ondansetron | 14 | $198 | $14 |
2021: 5 drugs
| Hydrocodone-Acetaminophen | 80 | $898 | $11 |
| Celecoxib | 18 | $866 | $48 |
| Diclofenac | 16 | $298 | $19 |
| Oxycodone-Acetaminophen | 30 | $280 | $9 |
| Tramadol | 16 | $46 | $3 |
2020: 6 drugs
| Enoxaparin | 14 | $1,320 | $94 |
| Celecoxib | 24 | $1,030 | $43 |
| Diclofenac | 29 | $947 | $33 |
| Hydrocodone-Acetaminophen | 66 | $645 | $10 |
| Oxycodone-Acetaminophen | 34 | $606 | $18 |
| Meloxicam | 14 | $35 | $2 |
2019: 6 drugs
| Diclofenac | 41 | $1,473 | $36 |
| Hydrocodone-Acetaminophen | 79 | $920 | $12 |
| Celecoxib | 24 | $710 | $30 |
| Oxycodone-Acetaminophen | 37 | $589 | $16 |
| Tramadol | 17 | $59 | $3 |
| Meloxicam | 12 | $21 | $2 |
2018: 3 drugs
| Celecoxib | 34 | $1,576 | $46 |
| Hydrocodone-Acetaminophen | 105 | $1,501 | $14 |
| Oxycodone-Acetaminophen | 26 | $457 | $18 |
2017: 4 drugs
| Celecoxib | 25 | $1,367 | $55 |
| Enoxaparin | 11 | $1,162 | $106 |
| Hydrocodone-Acetaminophen | 93 | $1,069 | $11 |
| Oxycodone-Acetaminophen | 25 | $673 | $27 |
2016: 5 drugs
| Enoxaparin | 36 | $4,975 | $138 |
| Hydrocodone-Acetaminophen | 56 | $1,378 | $25 |
| Celecoxib | 21 | $1,369 | $65 |
| Oxycodone-Acetaminophen | 14 | $539 | $39 |
| Tramadol | 12 | $94 | $8 |
2015: 5 drugs
| Xarelto | 22 | $4,118 | $187 |
| Celecoxib | 25 | $1,993 | $80 |
| Hydrocodone-Acetaminophen | 67 | $1,603 | $24 |
| Enoxaparin | 11 | $1,336 | $121 |
| Oxycodone-Acetaminophen | 11 | $564 | $51 |
2014: 3 drugs
| Xarelto | 18 | $3,291 | $183 |
| Oxycodone-Acetaminophen | 14 | $776 | $55 |
| Hydrocodone-Acetaminophen | 31 | $767 | $25 |
Money from drug and device companies
$300 in 2024
| 2024 | 2 | 2 | None | $300 |
| 2021 | 1 | 3 | None | $45 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bioventus | Durolane | $150 | 1 payment
|
| Medical Device Business Services | Ethicon | $150 | 1 payment
|
See all 2 published payments
| Bioventus | Meals · 2024-11-14 | Durolane | $150 |
| Medical Device Business Services | Meals · 2024-03-22 | Ethicon | $150 |
See earlier years (2021)
2021: $45
| Medical Device Business Services | Velys | $45 | 3 payments
|
Professional record
- NPI
- 1265783880
- Licence
- CA NP23190, WA AP60314068Washington ARNP.AP.60314068-NP: Expired
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 2350 W. El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2012-09-21
- NPI last updated
- 2013-11-14
This is when the NPI record was last certified, not a medical board exam.